or Try an Advanced Search...

    Biopharmaceutical Products Stocks List

    Symbol Grade Name % Change
    BMY F Bristol-Myers Squibb Company 0.17
    MRVI C Maravai LifeSciences Holdings, Inc. 0.91
    PHAR F Pharming Group N.V. -1.70
    RNA B Avidity Biosciences, Inc. 0.37
    RPRX F Royalty Pharma plc 0.59
    TKNO F Alpha Teknova, Inc. -4.47
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Pharmaceutical Products Biology Drug Therapies Molecular Diagnostics Pharmaceutical Acid Acute Kidney Injury Angioedema Antibody Assay Development Services Atrial Fibrillation Biopharmaceutical Development Bioprocess Bioprocessing Bioproduction C1 Inhibitor Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical Products stocks.

    Symbol Grade Name Weight
    XPH D SPDR S&P Pharmaceuticals ETF 8.22
    IHE D iShares U.S. Pharmaceutical ETF 8.2
    MOON F Direxion Moonshot Innovators ETF 7.43
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 6.73
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.34
    View all Biopharmaceutical Products ETFs...
    Compare ETFs
    Compare MOON to PILL Compare PILL to FTXH Compare XPH to PILL

        Biopharmaceutical Products Stocks Recent News

        Date Stock Title
        May 22 RPRX Cytokinetics to get up to $575M in funding from Royalty Pharma
        May 22 BMY Bristol-Myers Squibb snaps six days of losses, trades in the green
        May 22 RPRX Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
        May 22 RPRX Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
        May 22 BMY Bristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900M
        May 22 BMY Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
        May 22 BMY Pfizer to Cut Costs in Multi-Year Effort
        May 22 BMY Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
        May 22 BMY Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
        May 22 BMY Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
        May 22 BMY Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines
        May 22 BMY NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
        May 22 BMY Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
        May 21 PHAR Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
        May 21 BMY Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
        May 21 BMY 1 Stock I Wouldn't Touch With a 10-Foot Pole
        May 21 BMY Bristol-Myers says FDA has revised decision date on injected Opdivo
        May 21 BMY Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
        May 20 PHAR Pharming Group to participate in May investor conference
        May 19 RNA Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Pharmaceutical Products Biology Drug Therapies Molecular Diagnostics Pharmaceutical Acid Acute Kidney Injury Angioedema Antibody Assay Development Services Atrial Fibrillation Biopharmaceutical Development Bioprocess Bioprocessing Bioproduction C1 Inhibitor Cancer
        Biopharmaceutical Products

        Biopharmaceutical products are drugs or therapies that are produced using biotechnology. These products are created by manipulating living organisms or their components to make medicines that can be used to treat or prevent diseases. Examples of biopharmaceutical products include monoclonal antibodies, recombinant proteins, gene therapies, and vaccines.

        Browse All Tags